Genes known to be associated with active eosinophilic esophagitis. Selected genes known to be associated with active EoE from prior publications with benralizumab treatment patients compared to non-EoE controls (left) and patients with active EoE compared to non-EoE controls (right). Red indicates upregulated genes in benralizumab treated or active EoE with positive log2 fold-change/fold-change and blue indicates negative log2 fold-change/fold-change.